Novartis Ag (NVS) Exchange Rate Effect (2015 - 2026)

Novartis Ag's Exchange Rate Effect history runs 12 years deep, the most recent figure standing at -$77.0 million for Q1 2026.

• In Q1 2026, Exchange Rate Effect fell 142.78% year-over-year to -$77.0 million; the TTM figure through Mar 2026 stood at $319.0 million (up 3887.5% YoY), while the FY2025 annual figure was $576.0 million, up 293.29% from the prior year.
• Exchange Rate Effect came in at -$77.0 million for Q1 2026 at Novartis Ag, down from $36.0 million in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $382.0 million in Q2 2025 to a low of -$314.0 million in Q4 2024.
• A 5-year average of $15.8 million and a median of -$22.0 million in 2025 frame the typical range for Exchange Rate Effect.
• Across the five-year window, Exchange Rate Effect tumbled 3300.0% in 2024 and jumped 1223.53% in 2025, its largest moves.
• Novartis Ag's Exchange Rate Effect stood at $141.0 million in 2022, then increased by 13.48% to $160.0 million in 2023, then sank by 296.25% to -$314.0 million in 2024, then soared by 111.46% to $36.0 million in 2025, then tumbled by 313.89% to -$77.0 million in 2026.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered -$77.0 million, $36.0 million, and -$22.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison